Skip to content
Clinical Trials – home
Verifiedinfo

Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego

Poland Ul. Nowogrodzka 59, 02-006 Warsaw, Poland

  • 1 trial recruiting
  • IgA nephropathy · Glomerulonephritis membranoproliferative · Plasma cell myeloma
  • Adults and children

About Specializations

Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego in Warsaw, Poland specialises in clinical trials of conditions such as IgA nephropathy, Glomerulonephritis membranoproliferative, Plasma cell myeloma, Anti-glomerular basement membrane disease, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The medical center is at the forefront of cardiovascular research, focusing on innovative treatments for heart-related conditions. The center's work in this field is pivotal in advancing therapies for various heart diseases.

  • Acute Myocardial Infarction
  • Heart Failure with Reduced Ejection Fraction (HFrEF)
  • Arrhythmogenic Cardiomyopathy

Through its research, the center is contributing to the development of new therapeutic strategies that aim to improve patient outcomes and quality of life.

Endocrinology and Metabolic Disorders

Specializing in endocrinology and metabolic disorders, the center is dedicated to understanding and treating conditions such as diabetes and thyroid-related diseases. Its research is crucial in developing effective management strategies for these chronic conditions.

  • Type 1 Diabetes Mellitus
  • Thyroid Eye Disease (TED)
  • Hyperkalaemia

The center's research efforts are instrumental in creating innovative treatments that address the complex needs of patients with these disorders.

Oncology and Hematology

The center is renowned for its cutting-edge research in oncology and hematology, focusing on novel therapies for various cancers and blood disorders. This research is vital in the fight against these life-threatening diseases.

  • Myeloid Leukemia in Children with Down Syndrome
  • Chronic Lymphocytic Leukemia
  • Relapsed/Refractory Diffuse Large B Cell Lymphoma (R-R DLBCL)

By exploring new treatment avenues, the center is making significant strides in improving survival rates and quality of life for cancer patients.

Neurology and Muscular Disorders

Focusing on neurology and muscular disorders, the center is committed to advancing the understanding and treatment of neurological conditions. Its research is essential in developing therapies that enhance patient care and outcomes.

  • Spinal Muscular Atrophy (SMA)
  • Generalized Myasthenia Gravis
  • Duchenne Muscular Dystrophy (DMD)

The center's work in this area is paving the way for new treatments that offer hope to patients and their families.

Respiratory and Pulmonary Research

With a focus on respiratory and pulmonary research, the center is dedicated to improving the diagnosis and treatment of lung diseases. Its research is crucial in addressing the challenges posed by these conditions.

  • Idiopathic Pulmonary Fibrosis (IPF)
  • Interstitial Lung Disease
  • Progressive Pulmonary Fibrosis (PPF)

The center's innovative research is leading to breakthroughs that enhance the quality of life for patients with respiratory disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Nowogrodzka 5902-006 WarsawPoland
Recruiting now
1 trial
Conditions studied
4
Partner status
Verified

More sites in WarsawPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

6 clinical trials

Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Iptacopan
  • Sponsor:Novartis Pharma AG

IgA nephropathy

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ravulizumab
  • Sponsor:Alexion Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Celgene Corp.

IgA nephropathy

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Isis 696844
  • Sponsor:F. Hoffmann-La Roche AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Codeine Phosphate
  • Sponsor:F. Hoffmann-La Roche AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Hansa Biopharma AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.